2-(6-Chloropyridazin-3-yl)-2-phenylacetonitrile

Catalog No. :
ACYIGX197
CAS No. :
73535-73-6
Molecular Formula :
C12H8ClN3
Molecular Weight :
229.67

IUPAC Name:2-(6-chloropyridazin-3-yl)-2-phenylacetonitrile

2-(6-Chloropyridazin-3-yl)-2-phenylacetonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$50.00Login to see priceIn stockIn stock
1g95%$176.00Login to see priceIn stockIn stock
5g95%$704.00Login to see priceIn stockIn stock
25g95%$2534.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(6-Chloropyridazin-3-yl)-2-phenylacetonitrile
IUPAC Name2-(6-chloropyridazin-3-yl)-2-phenylacetonitrile
Molecular FormulaC12H8ClN3
Molecular Weight229.67
SMILESN#CC(C1=NN=C(Cl)C=C1)C2=CC=CC=C2
InChI KeyAVFQUMVXIBTANI-UHFFFAOYSA-N
SynonymAKOS016044771 | J-506166 | 2-phenyl-2-(6-chloro-3-pyridazinyl)acetonitrile | AKOS002666641 | AVFQUMVXIBTANI-UHFFFAOYSA-N | FT-0680430 | CS-0322514 | 2-(6-chloropyridazin-3-yl)-2-phenylacetonitrile, AldrichCPR | 6-Chloro-^a-phenyl-3-pyridazineacetonitrile
CAS No.73535-73-6
PubChem CID5706838

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYIGX197 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYIGX197 route product structure diagram
    ACYIGX19773535-73-6 In Stock
Inquiry

2. ACYIGX197 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACYIGX197 route product structure diagram
    ACYIGX19773535-73-6 In Stock
Inquiry

Comments (0)